94425 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
N-(BENZHYDRYL)CYCLOALKYLCARBOXAMIDE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF
#2DIARYLHYDANTOIN COMPOUNDS
#3HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS
#4MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF
#5FUNCTIONALIZED MATERIALS AND COMPOUNDS
#6DIARYLHYDANTOIN COMPOUNDS
#7Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
#8Open Time Additive
#9Hydantoin containing deoxyuridine triphosphatase inhibitors
#10DIARYLHYDANTOIN COMPOUNDS
#11Hydantoin containing deoxyuridine triphosphatase inhibitors
#12ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#13Electrolyte for the cyanide-free deposition of silver
#14Peripheral alkyl and alkenyl chains extended benzene derivatives and pharmaceutical composition including the same
#15Functionalized materials and compounds
#16Functionalized materials and compounds
#17Material for forming organic film, method for forming organic film, patterning process, and compound
#18DIARYLHYDANTOIN COMPOUNDS
#19Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
#20Nitrogen ring linked deoxyuridine triphosphatase inhibitors
#21Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
#22Hydantoin containing deoxyuridine triphosphatase inhibitors
#23Androgen receptor modulators and methods for their use
#24ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#25DIARYLHYDANTOIN COMPOUNDS
#26MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF
#27Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
#28Amino sulfonyl compounds
#29Nitrogen ring linked deoxyuridine triphosphatase inhibitors
#30DIARYLHYDANTOIN COMPOUNDS
#31MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT
#32PTEN binding compounds, formulations, and uses thereof
#335-substituted imidazole derivatives
#34Compounds, polymers and coating formulations that comprise at least one N-halamine precursor, a cationic center and a coating incorporation group
#35Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
#36Hydantoin containing deoxyuridine triphosphatase inhibitors
#37Hydantoin containing deoxyuridine triphosphatase inhibitors
#38Diarylhydantoin Compounds
#395-substituted imidazole derivatives
#40Ionic Liquid, Lubricant, and Magnetic Recording Medium
#41Selective histone deactylase 6 inhibitors
#42MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT
#43Recycling method
#44Apparatus for producing halohydantoin compound
#45Ethynyl derivatives
#46Imidazolidine-2,4-dione derivatives
#47Process for the preparation of -iodoamides
#48Selective histone deactylase 6 inhibitors
#49Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides
#50Method and apparatus for producing halohydantoin compound, recycling method, and halohydantoin compound
#51Inhibitors of peptidyl arginine deiminase (PAD) enzymes and uses thereof
#52Substituted B-amino acid derivatives as CXCR3 receptor antagonists
#53Compounds for treating proliferative disorders
#54Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists
#55Copolymers for near-infrared radiation-sensitive coating compositions for positive-working thermal lithographic printing plates
#56Multiple-component solid phases containing at least one active pharmaceutical ingredient
#57Specific diarylhydantoin and diarylthiohydantoin compounds
#58COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY
#59DIARYLHYDANTOIN COMPOUNDS
#60NOVEL N-PHENYLACETAMIDE DERIVATIVES, WHICH INHIBIT THE ENZYME SOAT-1, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
#61Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders
#62Treatment of hyperproliferative disorders with diarylhydantoin compounds
#63Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor
#64Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
#65Specific diarylhydantoin and diarylthiohydantoin compounds
#66N-phenylacetamide derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them
#67Imidazolidine derivative and use thereof
#68Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptor
#69DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#70Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders
#71Anti-wear agent, additive composition for lubricant, and lubricant composition
#72Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof
#73Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof
#74Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
#75Helix 12 directed non-steroidal antiandrogens
#76DIARYLHYDANTOIN COMPOUNDS
#77Treatment of hyperproliferative disorders with diarylhydantoin compounds
#781-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
#79WHOLE-CELL CATALYTIC SYSTEM COMPRISING A HYDANTOINASE, A RACEMASE AND A CARBAMOYLASE
#80Compound with anesthetics activity, methods for its production and pharmaceutical compositions comprising the same
#81Compounds for treating proliferative disorders
#82METHODS AND COMPOSITIONS FOR REVERSING P-GLYCOPROTEIN MEDICATED DRUG RESISTANCE
#83Process for preparing imidazolidin-2,4-dione compound and method for acquiring solid state 4,5-dihydroxy-2-imidazolidinone compound
#84Antidiabetic bicyclic compounds
#85Substituted hydantoins
#86INHIBITORS OF VIRAL REPLICATION
#87Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor
#88Sodium channel blockers
#89Non-nucleoside reverse transcriptase inhibitors
#90Hydroxy Alkyl Amines
#91PROCESS FOR PREPARING FOSPHENYTOIN
#92Pharmaceutical co-crystal compositions
#93Diarylhydantoin compounds
#94Helix 12 directed non-steroidal antiandrogens
#95Novel olanzapine forms and related methods of treatment
#961-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
#97N-halamine vinyl compounds and their polymeric biocides
#98Oral general anesthetics and metabolitically resistant anticonvulsants
#99Sodium channel blockers
#100Anti-cancer compounds and methods of use thereof